IPO Calendar
Lead Manager
- J P Morgan Chase (490)
- Goldman Sachs (463)
- Morgan Stanley (421)
- Bank of America Merrill Lynch (358)
- Citigroup (222)
- Jefferies (214)
- Credit Suisse (180)
- Barclays (151)
- Cowen and Company (147)
- Deutsche Bank (84)
- Piper Jaffray (70)
- Leerink Partners (70)
- Stifel (65)
- UBS Investment Bank (53)
- Evercore (52)
- RBC Capital (51)
- BMO Capital (49)
- Wells Fargo (47)
- Raymond James (38)
- William Blair (37)
More +
IPO - Pricing (7)
ThinkEquity
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23 | Inhibikase Ther | Health-Care | 10 | 1 | TEq | 249.7% | -1% | ||||
| Dec 17 | Virios Therapeu | Health-Care | 10 | 3 | TEq | 530.7% | 67.1% | ||||
| Nov 24 | Vision Marine T | Consumer-Services | 10 | 2 | TEq | 170.4% | 44.4% | ||||
| Oct 16 | Kiromic Biophar | Health-Care | 12 | 1 | TEq | 36.7% | -4.2% | ||||
| Aug 28 | Harbor Custom D | Basic-Industries | 6 | 1 | TEq | 105.9% | 25% | ||||
| Jul 31 | 1847 Goedeker I | Consumer-Durables | 9 | 1 | TEq | 76.7% | -1.1% | ||||
| Jan 29 | Annovis Bio Inc | Health-Care | 6 | 2 | TEq | 169.4% | 59.8% | ||||
*
Lead manager or one of top three managers in an underwriting team.